Axonal neuropathy immune-mediated by SARS-CoV2 (COVID-19): Report of two cases

In 2020, the World Health Organization declare a SARS-CoV-2 pandemic. There are currently more than 10 million people infected. Mao et al [1] demonstrated that 36.4% of hospitalized patients diagnosed with Covid-19 have presented neurological manifestations, where the most severe patients are more likely to develop said manifestations, with a percentage of them having presented the neurological alteration as the initial manifestation of COVID-19. Among the neurological manifestations of the disease already described, some authors have reported cases of GuillainBarré syndrome and its variants. In this article, we will report on two cases of axonal neuropathy mediated by SARS-Cov2.